BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 15327425)

  • 21. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
    Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
    Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose.
    Albrektsson A; Bazargani F; Wieslander A; Braide M
    ASAIO J; 2006; 52(3):276-81. PubMed ID: 16760716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
    Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
    Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Holmes CJ; Czekalski S; Breborowicz A; Lindholm B
    Blood Purif; 2009; 28(3):200-8. PubMed ID: 19648739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
    Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
    Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.
    Hoshino T; Kaneko S; Minato S; Yanai K; Mutsuyoshi Y; Ishii H; Kitano T; Shindo M; Miyazawa H; Aomatsu A; Ito K; Ueda Y; Hirai K; Ookawara S; Morishita Y
    Ther Apher Dial; 2018 Dec; 22(6):641-648. PubMed ID: 30014626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of new peritoneal dialysis solutions in children.
    Canepa A; Verrina E; Perfumo F
    Kidney Int Suppl; 2008 Apr; (108):S137-44. PubMed ID: 18379537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products.
    Wieczorowska-Tobis K; Brelinska R; Witowski J; Passlick-Deetjen J; Schaub TP; Schilling H; Breborowicz A
    Perit Dial Int; 2004; 24(1):48-57. PubMed ID: 15104336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
    Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
    Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U
    Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.
    Witowski J; Topley N; Jörres A; Liberek T; Coles GA; Williams JD
    Kidney Int; 1995 Jan; 47(1):282-93. PubMed ID: 7731159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of dialysis solution biocompatibility on ultrafiltration and on free water transport in rats.
    Aubertin G; Choquet P; Dheu C; Constantinesco A; Ratomponirina C; Zaloszyc A; Passlick-Deetjen J; Fischbach M
    Pediatr Nephrol; 2012 Jan; 27(1):131-8. PubMed ID: 21744055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.